Skip to content

Application of quantitative susceptibility mapping of brain iron content in children with autism

Application of quantitative susceptibility mapping of brain iron content in children with autism

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029699
Enrollment
Unknown
Registered
2020-02-09
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism

Interventions

Case versus control:Add ESWAN sequence scan

Sponsors

Children's Hospital Affiliated to Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 7 Years

Inclusion criteria

Inclusion criteria: Control group: 1. Children's body mass index was between 15 and 18; 2. Right handedness; 3. The children meet the diagnostic criteria of autism in DSM-IV, there are no neurological diseases, other organ associated diseases, other diseases that may affect brain function and structure, and no previous drug treatment history; 4. There are no abnormal in head routine MRI; Case group: 1. the body mass index of the children was between 15 and 18; 2. right handed, the children met the diagnostic criteria of autism in dsm-IV; 3. no neurological function disease, no other organ associated disease; 4. no other disease that may affect brain function and structure; 5. no previous drug treatment history; 6. no abnormal children were found in routine MRI of the head Child.

Exclusion criteria

Exclusion criteria: Control group: 1. Children with abnormal head MRI; 2. Children without right handedness; 3. Whose body mass index exceeds the average body mass index of this age group, that is, children with body mass index 18. Case group: 1. children with abnormal head MRI; 2. have neurological function disease, or other organ concomitant disease; 3. other diseases that may affect brain function and structure; 4. have a history of drug treatment.

Design outcomes

Primary

MeasureTime frame
Iron content;

Countries

China

Contacts

Public ContactShilong Tang

Children's Hospital Affiliated to Chongqing Medical University

sltang66@163.com+86 23-63632023

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026